Trichothecene mycotoxins have been reported to suppress or superinduce cytokine mRNA expression by leukocytes both in vitro and in vivo. Modulation of transcription factor activities may be critical for these observations. Here, the effect of trichothecene vomitoxin (VT, deoxynivalenol) on activator protein-1 (AP-1) activity was determined in the murine EL-4 thymoma. Electrophoretic mobility shift assay (EMSA) revealed that VT modulated AP-1 binding activity in a concentration-and time-dependent manner when using a synchronous model in which VT was added concurrently with phorbol 12-myristate 13-acetate (PMA) and ionomycin (ION) to EL-4 cells. Induction of AP-1 binding activity by PMA/ION was suppressed in the presence of VT for a short period (1 to 12 h), but was enhanced upon prolonged VT exposure (48 to 72 h). VT also enhanced AP-1 binding activity when added to the cell culture 12 h after PMA/ION activation (delayed synchronous model). Using specific antibodies against AP-1 complex proteins, it was demonstrated by gel supershift assay that VT preferentially affected phosphorylated c-Jun, Jun B, c-Fos, and Fra-2 binding activities, whereas it did not alter Jun D and Fra-1 binding. A transient transfection assay demonstrated that these increased binding activities are associated with enhanced AP-1 transactivation potential. Elevation of AP-1 activity may contribute to cytokine dysregulation and immunotoxic effects associated with exposure to trichothecene mycotoxins such as VT. © 2000
The trichothecene mycotoxins are a group of sesquiterpenoid fungal metabolites that include some of the most potent eukaryotic protein syntheses inhibitors known. Interest in the trichothecene mycotoxins arises from their adverse effects on human and animal health (Betina et al., 1989; Bhat et al., 1989) , their widespread contamination of agricultural commodities (Kotsonis et al., 1996) , and their recalcitrance to degradation during milling or processing (Scott, 1990) . Vomitoxin (VT, deoxynivalenol), a trichothecene mycotoxin produced by Fusarium graminearum, is frequently found in grainbased agricultural products, particularly in wheat, corn, and barley produced in the midwestern United States (Abouzied et al., 1991) . Our laboratory has observed that ingestion of VT results in elevated serum IgA and IgA nephropathy in mice (Bondy and Pestka, 1991; Dong and Pestka, 1993; Pestka et al., 1989) . Furthermore, in vitro and in vivo studies have shown that VT-induced IgA nephropathy in mice may be mediated through the superinduction of gene expression of several cytokines that include interleukin (IL)-2 and IL-6 (Azcona- Olivera et al., 1995a,b; Dong et al., 1994; Ouyang et al., 1996a,b; Li et al., 1997; Yan et al., 1997 Yan et al., , 1998 .
Transcriptional regulation is a primary strategy to control gene expression by organisms in response to either physiological or environmental stress signals (Scheidereit, 1996) . These signals activate a network of signal transduction pathways and subsequently induce relevant transcription factor activities. Activated transcription factors coordinately modulate the target gene expression via binding to the specific DNA sequences located in the promoter or enhancer. Modulation of transcription factor activities by VT and other trichothecenes may be the underlying transcriptional mechanisms responsible for cytokine superinduction. Both IL-2 and IL-6 gene transcription are tightly and integrally controlled by multiple transcription factors (Serfling et al., 1995; Akira and Kishimoto, 1997) . For example, transcription factor NF-B plays a critical role in the regulation of transcription of several cytokine genes (Blackwell and Christman, 1997) . VT exposure can enhance NF-B binding activity by inhibiting the synthesis of IB␣, which is a negative regulator of NF-B (Ouyang et al., 1996b) . Besides NF-B, activator protein-1 (AP-1) is another critical transcription factor involved in transcriptional regulation of IL-2 and IL-6 gene expression (Serfling et al., 1995; Kick et al., 1995) .
AP-1 is composed of members of the Jun and Fos families, which bind to the TPA response element (AP-1 site). To date, three Jun family proteins, JunB, c-Jun and JunD, and four Fos family members, c-Fos, FosB, Fra-1 and Fra-2, have been identified. Jun family proteins can form either homodimers or heterodimers with Fos proteins, while Fos proteins can only dimerize with Jun members (Angel and Karin, 1991) . Notably, AP-1 activity can be modulated by physiological signals such as growth factors as well as environmental stress signals such as ionizing radiation, oxidation, heat shock, UV light, and environmental chemicals and this can subsequently alter the expression of the target genes (Herrlich et al., 1992; Sachsenmaier et al., 1994; Guyton et al., 1996) .
The objective of this study was to test the hypothesis that VT alters AP-1 binding activity in T cells. Based on their previous use for evaluating VT-induced cytokine dysregulation (Dong et al., 1994; Ouyang et al., 1996b) , EL-4 thymoma cells were used as a model for T helper lymphocytes. The results suggested that, while short-term VT exposure downregulated AP-1 activity, prolonged exposure to VT enhanced AP-1 binding activities primarily by targeting phosphorylated c-Jun and, to a lesser extent, c-Fos, Fra-2, and Jun B. Alterations in AP-1 activity may contribute to previously observed VT-mediated cytokine dysregulation.
MATERIALS AND METHODS
Reagents and cell culture. All reagents were purchased from Sigma Chemical (St. Louis, MO) unless otherwise noted. The murine EL-4.IL-2 (EL-4) cell line was obtained from American Type Culture Collection (Rockville, MD). Reagent preparation and cell culture were performed as previously described (Ouyang et al. 1996b) . EL-4 cells (5 ϫ 10 5 cells/ml) were activated with 20 ng/ml phorbol 12-myristate 13-acetate (PMA) plus 1 M ionomycin (ION) (PMA/ION). VT was either added concurrently with PMA/ION (synchronous model) or 12 h after stimulation with PMA/ION (delayed synchronous model) (Li et al., 1997) .
Preparation of nuclear extracts. Cells were collected and subcellular protein extracts were prepared as described previously (Ouyang et al., 1996b) . Briefly, the cell pellet was washed once in 1 ml phosphate-buffered saline (0.01 M, pH 7.4) and carefully resuspended in 300 l buffer A (10 mM HEPES [pH 7.9], 10 mM KCl, 0.1 mM EDTA, 0. The lysate was microcentrifuged at 12,000g for 10 min. The supernatants were collected as nuclear extracts, supplemented with 25 g/ml leupeptin, aliquoted, and stored at Ϫ80°C until analysis. Protein concentrations were determined using a Bio-Rad Protein Assay kit (Bio-Rad Laboratories Inc., Melville, NY) according to manufacturer's protocol.
Electrophoretic mobility shift assay (EMSA). AP-1 binding activity in nuclear extracts was evaluated by EMSA (Ouyang et al., 1996b) . The probe was labeled with [ ␥-32 P]ATP using Ready To-Go T 4 Polynucleotide Kinase according to manufacturer's protocols (Pharmacia Biotech Inc., Piscataway, NJ). Nuclear extracts (10 g) were added to DNA binding reaction buffer (15 mM Tris [pH 7.5], 75 mM NaCl, 1.5 mM EDTA, 1.5 mM DTT, 20 g/ml BSA, 0.3% [v/v] NP-40, and 2 g poly d(I-C), 7.5% [v/v] glycerol, total volume 24 l) and preincubated on ice for 30 min to block the nonspecific binding. Next, 40 K cpm 32 P-labeled double-stranded AP-1 consensus binding site 5Ј-CGCTTGATGACTCAGCCGGAA-3Ј (Santa Cruz Biotech, Santa Cruz, CA) was added and incubated at room temperature for 30 min for the formation of nucleoprotein. For competition assays, 25 or 50 times excess of unlabeled double-stranded AP-1, mutant AP-1 [5Ј-CGCTTGATGACTTGGC-CGGAA-3Ј] and nonspecific oligonucleotide NF-B [5Ј-AGTTGAGGG-GACTTTCCCAGGC-3Ј] probes (Santa Cruz Biotech) were added prior to addition of labeled probe. For the supershift assay, 2 g rabbit polyclonal IgG specific for JunB, c-Jun (Ser63-phosphate), JunD, FosB, c-Fos, Fra-1, Fra-2, or 2 g rabbit polyclonal IgG control antibody (Santa Cruz Biotech) was added to DNA binding reaction buffer and preincubated on ice for 1 h prior to adding the probe. Antibody c-Jun (Ser63-phosphate) specifically targeted phosphorylated c-Jun, while others bound both phosphorylated and nonphosphorylated target proteins. Resultant nucleoprotein complexes were resolved on native 4% polyacrylamide gels, dried, and visualized by autoradiography.
Transient transfection. An AP-1 luciferase reporter construct (7xAp-1-Luc reporter construct (Stratagene, La Jolla, CA) was transiently transfected by electroporation using a modification of the method of Nelson et al. (1996) . Briefly, 5 ϫ10 6 EL-4 cells were suspended in 650 l of DMEM with 10% (v/v) FBS and 5 g AP-1 reporter construct in a 0.4-cm Gene Pulser cuvette (Bio-Rad Laboratories, Hercules, CA) and then preincubated for 5 min at room temperature. Electroporation was carried out by a single pulse 300 V and 960 F in the Gene Pulser (Bio-Rad Laboratories). After electroporation, cells were incubated on ice for 10 min, transferred to 100 ϫ 20-mm tissue dishes containing 10% (v/v) FBS-DMEM medium, and cultured overnight at 37°C. After washing, transfected cells were pooled, split, and treated with PMA/ION and VT in synchronous or delayed synchronous fashions. Total RNA was extracted as described previously (Ouyang et al., 1996a) for analysis of AP-1 controlled luciferase mRNA and housekeeping gene cyclophilin mRNA.
Semiquantitative reverse transcriptase-polymerase chain reaction (RT-PCR).
RT reactions were carried out according to the procedures described by (Ouyang et al. 1996a) . Primers were synthesized at Michigan State University Macromolecular Structure facility and contained the following sequences luciferase (luc), 5Ј-GGCAGAAGCTATGAAACG-3Ј, 5Ј-GAC-GAACGTGTACATCGAC-3Ј; luciferase mimic (luc mimic), 5Ј-GG-CAGAAGCTATGAAACGCGCAAGTGAAATCTCCTCCG-3Ј, 5Ј-GAC-GAACGTGTACATCGACATTTGATTCTGGACCATGGC-3Ј; and yclophilin (cyc) (used to control for variations in RT-PCR), 5Ј-CTTCGACATCACG-GCTGATGG-3Ј, 5Ј-CAGGACCTGTATGCTTCAGG-3Ј. Semiquantitative analysis of luciferase mRNA was performed by competitive PCR (Kramnik et al., 1993) using 20 twofold serial dilutions of a mimic luciferase DNA template (10 pmol) from PCR MIMIC construction kit (Clontech, Palo, Alto, CA). The mimic luciferase DNA was used as internal standard to control the amplification efficiency. This PCR mimic was made from a nonhomologous competitive DNA molecule containing primer templates on both end sites and was capable of competing with the target luciferase cDNA. The amplification was performed in a 9600 Perkin Elmer Cycler (Perkin-Elmer Corp., Norwalk, CT) using the following parameters: denature at 94°C for 45 s, annealing at 62°C for 45 s, and elongation at 72°C for 1.5 min. Each target cDNA was amplified for 10, 15, 20, 25, 30, 35 , and 40 cycles to define optimal cycle number for linearity. Absence of transfected DNA contamination in each RNA sample was checked directly by PCR amplification in the absence of RT. An aliquot (15 l) of each PCR product was subjected to electrophoresis in 2% (w/v) agarose gels and visualized by staining with ethidium bromide. Resultant gels were then photographed using 670 Polariod film (Polaroid, Cambridge, MA). These were scanned by an Epson ES-1000C Laser Scanner (Seiko Epson, Torrance, CA) and intensities were quantified using Sigma Gel Software (Jandel Scientific, San Rafael, CA). The concentrations of the luc mimic equal to those of luc cDNA product in control group and VT-treated group were determined by aforementioned serial dilutions of luc mimic. Based on these equal concentrations (0.30 -1.2 attomole for different models), the relative mRNA levels between control and VT-treated were further compared in the different models. The relative luciferase mRNA levels were determined by the normalization of intensity ratio of target DNA and mimic DNA against the intensity for housekeeping gene cyclophilin (Morris and Davila, 1996) .
RESULTS

Effects of VT on AP-1 binding activities in a synchronous
model. When the effect of VT on AP-1 activity in EL-4 cells was evaluated by EMSA, VT was found to modulate binding in a time-dependent fashion (Fig. 1) . Short time VT exposure (250 ng/ml, 1-12 h) resulted in suppressed PMA/ION-induced AP-1 binding activity compared to corresponding controls (without VT). However, this inhibition gradually diminished with prolonged VT exposure. At 24 h, AP-1 binding activity in the VT group was similar to that of control. Extending exposure to 48 and 72 h resulted in enhanced AP-1 binding activity compared to corresponding controls.
VT also modulated AP-1 binding activity in a concentrationdependent fashion (Fig. 2) . High concentrations of VT (250 to 1000 ng/ml) inhibited AP-1 binding activity at early time points (1 and 4 h) while low concentrations (50 to 100 ng/ml) had minimal effects on the binding activity. However, after 48 h, VT at all concentrations employed (50 to 1000 ng/ml) enhanced AP-1 binding activity compared to the control (Fig. 2) .
Specificity of the DNA-protein complex was verified by competition with excess of unlabeled AP-1, mutant AP-1, or NF-B probes (Fig. 3) . AP-1 binding was blocked by competition with either 25-or 50-fold excess of unlabeled AP-1. In contrast, excess of unlabeled mutant AP-1 or nonspecific oligonucleotide NF-B probes had no effect on the complex formation.
Effects of VT on AP-1 binding activities in a delayed synchronous model. A delayed synchronous model was used to determine whether modulation of AP-1 binding activity would also occur when VT was presented 12 h after PMA/ION activation. Twenty-four to 48 h after addition, VT enhanced AP-1 binding activity in a concentration-dependent fashion from 100 to1000 ng/ml (Fig. 4) .
Identification of VT-modulated components in AP-1 complex.
To assess the individual contribution of Jun and Fos proteins to VT-induced modulation of AP-1 binding, a supershift EMSA was conducted with a panel of specific antibodies. In the synchronous model, supershift EMSA revealed that binding activities were associated with phosphorylated c-Jun, JunB, FosB, and Fra-2, whereas the contribution by JunD or c-Fos was time-dependent and Fra-1 made little contribution to the binding activity (Figs. 5, 6 , and 7). VT suppressed binding activities of each target protein at 3 h post activation (Fig. 5 ) but enhanced binding activities at 48 h (Fig. 6) , which was consistent with time-dependent modulation by VT as seen in Figs. 1 and 2 (i.e., inhibition at early time point and enhancement in later time point). Using a cocktail of antibodies against c-Jun, JunB, and JunD, or against c-Fos, FosB, and Fra-2 (Fig.  6) , supershift EMSA verified that total AP-1 binding activity in VT-treated cells was higher than that in control. No band shift or retardation was observed using control antibodies, thus further verifying the specificity of supershifted bands by target antibodies (Fig. 6) . Similar effects on the composition of AP-1 complex by VT were demonstrated in the delayed synchronous model (Fig. 7) . Thus, among potential AP-1 components, c-Jun is not only a major contributor to AP-1 DNA binding activities but also appears to be a major target for VT.
Effects of VT on AP-1 transactivation potential. Since VT elicited a biphasic effect on AP-1 binding activity (Figs. 1 and  2) , it was possible that later enhancement in AP-1 binding activity by VT contributed to a corresponding increased transactivation potential. Therefore, the effects of prolonged VT exposure on the AP-1 transactivation potential were evaluated in EL-4 cells transiently transfected with luciferase reporter construct driven by AP-1 binding sites. Because of the potential confounding effects of VT on translation of the luciferase protein, the relative luciferase mRNA levels were determined by RT-PCR to directly assess the effects of the toxin on transcription. Consistent with the binding study, expression of luciferase mRNA in VT-exposed cells was 122 and 181% of control values at 48 and 72 h, respectively, in the synchronous model (Fig. 8A) . Similarly, expression of luciferase mRNA in VT-exposed cells was 124 and 297% of control values at 48 and 72 h, respectively, in the delayed synchronous model (Fig.  8B) . Thus, increased AP-1 binding activities observed in VTexposed cells were associated with increased transactivation potential for genes containing AP-1 binding sites in their promoters.
DISCUSSION
AP-1 is a transcription factor that is of critical importance in the regulation of immune function, particularly with respect to control of early T cell activation and immunoglobulin production by B cells (Foletta et al., 1997) . The extent and outcome of AP-1 binding is determined by various combinations between Jun and Fos family members or Jun in conjunction with transcription factors such as NF-B (Shapiro et al., 1996) .
FIG. 4.
Effect of VT on AP-1 binding activity in the delayed synchronous exposure model. EL-4 cells were first stimulated with PMA (20 ng/ml) and ION (1 M) for 12 h and then were treated with or without VT (100 to 1000 ng/ml) for 24 to 72 h. Nuclear protein extracts (5 g/lane) were subjected to EMSA. Hours refer to the time after VT addition. Results are representative of two separate experiments. c-Jun is a central constituent of all AP-1 complexes (Karin, 1995) , and phosphorylation of c-Jun can lead to a pronounced increase of transactivation potential (Hibi et al., 1993) . In this study, synchronous and delayed synchronous exposure models were employed to mimic possible in vivo scenarios whereby T cells are exposed to VT in the context of simultaneous or prior coactivation signals, respectively, as mimicked by PMA/ION (Li et al., 1997) . It was demonstrated that, in PMA/IONstimulated EL-4 cells, VT can modulate AP-1 activities either negatively or positively in concentration-and time-dependent fashions. Other key findings were that VT preferentially targeted phosphorylated c-Jun binding activity and, moreover, that enhanced binding activity by VT may lead to increased transactivation.
The mechanisms for regulating AP-1 activity in activated T cells are very complex. Increased amounts of different AP-1 components and posttranslational modification like phosphorylation in response to mitogens such as PMA are certainly essential (Karin et al., 1997) . It is reasonable to suggest that, as a potent protein synthesis inhibitor, VT may inhibit de novo synthesis of AP-1 components and thus contribute to the concentration-dependent suppression of PMA/ION-stimulated AP-1 binding activities. Consistent with this premise, protein synthesis inhibitors such as cycloheximide can inhibit early induction of AP-1 binding activities induced by either toxic shock syndrome toxin-1 or staphlococcal exotoxin A in a human acute monocytic leukemia cell line (Trede et al., 1993) , by okadaic acid in mouse keratinocyte cells (Rosenberger and Bowden, 1996) , and by PMA in lapine synovial fibroblasts (Lin et al., 1996) . Inhibition of AP-1 binding activity by protein synthesis inhibitors was also observed in vivo where injection of cycloheximide resulted in suppression of growth hormone-induced AP-1 binding activities in rat liver cells (Gronowski et al., 1996) .
It is perplexing that inhibition of AP-1 binding activity was reversible in the continued presence of VT and, moreover, that extended VT exposure (Ͼ24 h) led to upregulation of AP-1 binding activity. Cycloheximide has also been observed to enhance AP-1 activity, including both binding and transactivation potential (Roger et al., 1998) . The mechanisms for the VT-mediated AP-1 activity upregulation are not clear yet. However, the supershift EMSA results suggest that VT may upregulate the phosphorylation of c-Jun. Phosphorylated c-Jun has high transactivation potential (Karin et al., 1997) VT (250 ng/ml) in the synchronous exposure model were subjected to supershift EMSAs using specific antibodies to JunB, c-Jun, JunD, FosB, c-Fos, Fra-1, and Fra-2. SSB, supershift bands. (Musti et al., 1997) . The activity of SAPKs can be induced by a variety of cellular stress signals such as heat shock, UV light, cytokines, and, notably, protein synthesis inhibitors (Kyriakis et al., 1994; Iordanov et al., 1997) . Recently, Shifrin and Anderson (1999) have shown that several trichothecenes, including VT, can strongly activate JNK/p38 kinases via a putative "ribotoxic" stress response. Thus, it is very possible that VT induces SAPK-mediated phosphorylation of c-Jun and increases AP-1 activity.
AP-1 is a critical transcription factor involved in IL-2 gene expression (Serfling et al., 1995) . IL-2 is essential for T cell activation, differentiation, and T cell-dependent immune responses. VT exposure induces in mice an autoimmune disease that is very similar to human IgA nephropathy (Bondy and Pestka, 1991; Dong and Pestka, 1993; Pestka et al., 1989) , and this may be mediated by several T helper cytokines that include IL-2 (Azcona- Olivera et al., 1995a ,b; Yan et al., 1997 Yan et al., ,1998 . Using similar concentrations (50 -1000 ng/ml) as used in this study, it was previously established that VT superinduces IL-2 expression mRNA and the protein levels in both EL-4 and primary CD4
ϩ cells that were stimulated with PMA and ION (Dong et al., 1994; Ouyang et al., 1995) . Notably, this toxin concentration range was observable in serum and other tissues in an in vivo toxicokinetic study when VT was administered at doses identical to those that cause superinduction of IL-2 mRNA in spleen and Peyer's patches following in vivo exposure (Azcona-Olivera et al., 1995b; Zhou et al., 1997) . The response kinetics of high concentrations of VT (250 ng/ml) on AP-1 binding activity were comparable to that of VT on IL-2 expression in primary CD4 ϩ cells, which also exhibited an
FIG. 6.
Comparative analysis of AP-1 DNA binding complexes in 48-h synchronous cultures. Nuclear protein extracts (5 g/lane) from 48-h cultures treated with or without VT (250 ng/ml) in the synchronous exposure model subjected to supershift EMSAs using specific antibodies to JunB, c-Jun, JunD, FosB, c-Fos, Fra-1, and Fra-2. Control antibodies were mouse IgG, rabbit IgG, and goat IgG, respectively. SSB, supershift bands.
inhibition-induction pattern (Ouyang et al., 1995) . Our results suggest that VT-modulated AP-1 activities could be responsible, in part, for VT-induced dysregulation of IL-2 expression and potentially that of other cytokines under similar promoter control.
Taken together, this study demonstrated that VT modulated transcription factor AP-1 activities in a concentration-and time-dependent fashion in EL-4 cells and further identified c-Jun to be a major target. Comparison of the kinetics of VT-induced modulation of AP-1 activity to previously described kinetics of IL-2 expression suggest that altered AP-1 activity by VT may be an underlying mechanism for VTinduced dysregulation of IL-2 expression. Future studies focusing on upstream signaling events prior to AP-1 activation should further advance our understanding of the molecular mechanisms for trichothecene-mediated immune dysfunction.
FIG. 7.
Comparative analysis of AP-1 DNA binding complexes in 24-h delayed synchronous cultures. Nuclear protein extracts (5 g/lane) from 24-h cultures treated with or without VT (250 ng/ml) in the delayed synchronous exposure model were subjected to supershift EMSAs using specific antibodies to JunB, c-Jun, JunD, FosB, c-Fos, Fra-1, and Fra-2. SSB, supershift bands.
FIG. 8.
VT-modulated AP-1 transactivation. AP-1 luciferase reporter construct was transfected in EL-4 cells as described in materials and methods in a synchronous (A) or delayed synchronous fashion (B). VT was added at 500 and 250 ng/ml to synchronous and delayed synchronous cultures, respectively. The numbers below the bands are indicative of relative luciferase mRNA levels as determined under Materials and Methods. Results are representative of three separate experiments.
